BioForce Nanosciences Holdings, Inc.

BioForce Nanosciences Holdings, Inc.

BFNH
BioForce Nanosciences Holdings, Inc.US flagOther OTC
1.32
USD
+0.47
- -
44.28MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
-9.72
-0.02
-0.02
-0.02
-0.02
-0.04
-0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
- -
- -
-0.04
-0.04
-0.05
-0.05
-9.76
-5.45
-5.47
-5.49
-5.5
-4.89
-4.85
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
-0.02
-0.03
-0.05
-0.06
-0.08
-0.02
-0.02
Basic Weighted Avg Shares
7
7
7
15
15
15
15
16
29
29
29
29
33
34
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
82.96
- -
- -
-69.24
-694.69
-409.2
-261.82
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
-158
-1
- -
- -
- -
-1
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
82.96
- -
- -
-69.24
-694.69
-415.32
-261.82
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-2
-2
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
-2
-2
-1
-1
Return on Invested Capital (%)
86.37
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-22.56
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
34
34
34
Market Capitalization
20
19
12

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-18.38%
36.84%
-73.13%
Free Cash Flow
- -
-1.85%
6.37%
Net Income, GAAP
34,100.81%
12.32%
163.43%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.02
2025
-0.03
- -
- -
- -
-0.04
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Steven Gagnon
Full Time Employees
3
Sector
Consumer Defensive
Industry
Packaged Foods
Address
2020 General Booth Boulevard Virginia Beach VA United States of America 23454
IPO Date
May 1, 2007
Business
BioForce Nanosciences Holdings, Inc. engages in the provision of natural vitamins, minerals, nutritional supplements, powders, and beverages designed to promote healthier lifestyles for active individuals across various age groups. The company offers private label nutritional products distributed through nutrition retailers, sporting goods stores, supermarkets, mass merchandisers, and online channels including its BioForce Eclipse brand retailed at www.bioforceeclipse.com. Founded in 1999 and headquartered in Virginia Beach, Virginia, BioForce Nanosciences Holdings, Inc. focuses on expanding its flagship BioForce Eclipse nutritional powder product into household markets across the United States. Recent developments include strategic efforts to broaden distribution and increase consumer penetration through retail and e-commerce platforms, alongside marketing via social media and telemarketing channels. The company's product portfolio and operational emphasis reflect its core business in health supplements targeting active lifestyle consumers with an expanding footprint in the U.S. nutrition retail sector.